Home > Journals > Esperienze Dermatologiche > Past Issues > Esperienze Dermatologiche 2021 June;23(2) > Esperienze Dermatologiche 2021 June;23(2):29-32

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   

Esperienze Dermatologiche 2021 June;23(2):29-32

DOI: 10.23736/S1128-9155.21.00520-3

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English, Italian

A cosmetic preparation for the prevention of pigmentation after laser treatment of solar lentigines

Diletta BONCIANI 1 , Giovanni CANNAROZZO 2

1 Unit of Dermatology, San Jacopo Hospital, Pistoia, Italy; 2 Unit of Dermatology, Tor Vergata University, Rome, Italy


PDF


BACKGROUND: Post-inflammatory hyperpigmentation (PIH) after solar lentigo removal using a Q-switched (QS) 532-nm Nd:YAG laser is a cause for concern. This study aimed to evaluate the efficacy and safety of a new depigmenting cosmetic for the prevention of PIH after QS 532-nm Nd:YAG laser treatment of solar lentigines.
METHODS: In total, 20 patients with solar lentigines on the face underwent QS 532-nm Nd:YAG laser treatment. Then, the cosmetic treatment was applied from the day 5 after the treatment for 3 weeks, in 10 patients and only sunscreen was applied in the other 10 patients; treatments were randomly assigned. Two blinded dermatologists evaluated photographs at baseline, and at week 4.
RESULTS: The tolerability of the cosmetic treatment was excellent or good in all patients; the tolerability of the sunscreen was excellent or good in 80% of patients and moderate in 20%. PIH was observed only in one (10%) patient after the cosmetic treatment, but it was present in six (60%) of those receiving the sunscreen (P=0.022 vs. cosmetic treatment). The relative risk of developing PIH in patients treated with the cosmetic treatment versus sunscreen was 0.17 (95% CI: 0.02-1.14, P=0.068).
CONCLUSIONS: The use of this cosmetic treatment after 532-nm QS Nd:YAG laser treatment of solar lentigines can reduce the risk of developing PIH after 4 weeks.


KEY WORDS: Hyperpigmentation; Laser therapy; Lentigo; Prevention and control; Skin lightening preparations

top of page